Skip to main content
. 2022 Sep 21;12:900010. doi: 10.3389/fonc.2022.900010

Table 4.

Percentage of cases in which clinical benefit regarding pain, range of joint motion, and joint function compared with that of baseline is observed at 24 weeks and 48 weeks.

Group N Clinical benefit p
Yes No 95%CI
Zaltoprofen 21 9 (42.9%) 12 (57.1%) [21.8 - 66.0] 1
Placebo 20 8 (40.0%) 12 (60.0%) [19.1 - 63.9]